Filtern
Volltext vorhanden
- ja (13)
Gehört zur Bibliographie
- ja (13)
Dokumenttyp
Schlagworte
- drug adverse reaction (3)
- drug allergy (3)
- drug hypersensitivity (3)
- allergy (2)
- anaphylaxis (2)
- penicillin allergy (2)
- penicillin hypersensitivity (2)
- urticaria (2)
- ACE inhibitor (1)
- Anaphylaxis (1)
- Beta-blocker (1)
- Crohn disease (1)
- Cutaneous metastatic Crohn’s disease (1)
- Double sensitization (1)
- ET-37 Komplex (1)
- ET-37 complex (1)
- Field sting (1)
- Honey bee (1)
- Hymenoptera venom (1)
- Immunotherapy (1)
- Neisseria meningitidis (1)
- Plasmid (1)
- Relapse (1)
- Risk factor (1)
- Treatment failure (1)
- Vespula (1)
- age (1)
- agranulocytosis (1)
- algorithm (1)
- amoxicillin (1)
- ampicillin (1)
- angioedema (1)
- antibiotic (1)
- aspirin‐exacerbated respiratory disease (1)
- bee (1)
- buildup phase (1)
- cicatricial pemphigoid (1)
- drug exanthema (1)
- exanthem (1)
- fixed drug eruption (1)
- hereditary alpha-tryptasemia (1)
- histologic findings (1)
- hymenoptera (1)
- immunotherapy (1)
- laminin 332 (1)
- leg cramps (1)
- long-term outcome (1)
- mastocytosis (1)
- mucous membrane pemphigoid (1)
- oesophagogastroduodenoscopy (1)
- orofacial granulomatosis (1)
- over-the-counter drugs (1)
- pJS-A (1)
- pJS-B (1)
- pediatric (1)
- plasmid (1)
- pustular exanthema (1)
- quinine (1)
- risk factor (1)
- treatment options (1)
- vespula (1)
There is a lack of standardized treatment recommendations for orofacial granulomatosis, a chronic inflammatory condition aetiologically related to Crohn disease. To assess clinical baseline parameters and treatment strategies, we retrospectively analysed 61 consecutive cases from our institutional database. Disease-related functional/psychological impairment and long-term outcomes were descriptively evaluated using a standardized self-reporting questionnaire. The median age of patients was 45 (7–77) years. Oral steroids were given in 41.0% of cases, but only produced short-term disease control, while response to steroid-sparing agents was inconsistent. Only a minority of patients reported relevant disease-related functional impairment in eating (21.7%) or speaking (4.3%), but the majority perceived psychological distress due to the cosmetic aspects of the disease (69.6%), comments from others (65.2%) and/or general anxiety/insecurity (73.9%). Regardless of the initial treatment, long-term outcomes after 71 months (range 7–304 months) were beneficial, with most patients being in complete remission (52.2%) or reporting only mild residual swelling (43.5%).